Peer Review Process
Peer Review Process
To ensure the highest standard of scientific integrity and academic rigor, all submitted manuscripts to Holistica Pharmatica Scientia undergo a stringent double-blind peer-review process. This process guarantees that both the reviewers and the authors remain anonymous to each other throughout the evaluation.
Figure 1. Detailed Peer Review Workflow
The editorial workflow is divided into three major phases:
1. Initial Screening (1-2 Weeks): Upon submission, the Editor-in-Chief or Section Editor performs an initial check for scope alignment, technical completeness, and plagiarism (similarity limit < 20%). Manuscripts that do not meet the basic criteria are returned to authors or declined.
2. Review Process (2-4 Weeks): Qualified manuscripts are sent to at least two independent peer reviewers. Reviewers assess the originality, methodology, and significance of the research. Based on their reports, the Editor makes a decision: Accept, Minor Revisions, Major Revisions, or Decline.
3. Final Process (1-2 Weeks): Accepted manuscripts undergo professional copyediting, layout formatting, and proofreading. Once the final proof is approved by the author, the article is assigned a DOI and published online as part of the current issue.
This meticulous workflow ensures that every paper published in our journal contributes substantively to the global advancement of pharmaceutical and health sciences.
